EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer

Alejandro Ríos-Hoyo iD, Erin Cobain, Laura A Huppert, Peter D Beitsch, Thomas A Buchholz, Laura Esserman, Laura J van 't Veer, Hope S Rugo, Lajos Pusztai iD

Journal of Clinical Oncology · 2024

DOI: 10.1200/jco.23.02614 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Alejandro Ríos-Hoyo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cancer Center, Yale School of Medicine, New Haven, CT. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Erb-b2 Receptor Tyrosine Kinases, Receptors, Estrogen. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoadjuvant TherapyErb-b2 Receptor Tyrosine KinasesReceptors, EstrogenHumansFemaleImmunotherapyAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, Adjuvant

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenERBB2 protein, human

Autor:innen und Institutionen

  • Yale Cancer Center, Yale School of Medicine, New Haven, CT.
  • University of Michigan, Ann Arbor, MI.
  • University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.
  • Dallas Surgical Group, Dallas, TX.
  • Scripps Health, Scripps Clinic Medical Group, San Diego, CA.

ORCID-Profile: Alejandro Ríos-Hoyo, Lajos Pusztai

Zitieren

APA

Ríos-Hoyo, A., Cobain, E., Huppert, L. A., Beitsch, P. D., Buchholz, T. A., Esserman, L., van 't Veer, L. J., Rugo, H. S., & Pusztai, L. (2024). Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.02614

Vancouver

Ríos-Hoyo A, Cobain E, Huppert LA, Beitsch PD, Buchholz TA, Esserman L, et al. Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer. Journal of Clinical Oncology. 2024. doi:10.1200/jco.23.02614

BibTeX
@article{RosHoyo2024,
  author = {Ríos-Hoyo, Alejandro and Cobain, Erin and Huppert, Laura A and Beitsch, Peter D and Buchholz, Thomas A and Esserman, Laura and van 't Veer, Laura J and Rugo, Hope S and Pusztai, Lajos},
  title = {Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/jco.23.02614}
}
Kostenlos starten →